Skip to main content

Latest News

Governor visits MSWA Centre in Bunbury

14th November 2017

Western Australian Governor and MSWA patron, Her Excellency the Honourable Kerry Sanderson AC, recently visited the organisation’s $1.5 million Community and Health Services Centre in Bunbury. The new state-of-the-art Centre is a one-stop shop for the 200 people with multiple sclerosis and other neurological conditions and their carers living in the region.

Read More
article.heroMedia.text

MSWA funds stroke protection research

30th October 2017

In an effort to help reduce the damage caused by a stroke, MSWA is investing $250,000 to fund local research into determining the effectiveness of peptide treatment in reducing damage to the brain after a stroke.

Read More
article.heroMedia.text

MSWA invests record $2.6m into research

19th September 2017

MSWA is extremely proud to announce another record breaking contribution of $2.6 million to neurological research this year – the largest in Australia’s history.

Apart from the regular and ongoing support of a range of MS research projects, this includes:

  • $500,000 to the international research programme into progressive multiple sclerosis (MS);
  • $500,000 to WA research projects; and
  • $350,000 for research into other neurological conditions.

All of this would not be possible without the support of the people of Western Australia. MSWA thanks you for either donating, fundraising and taking part in one of our events or buying a lottery ticket. This generosity allows us to continue our ability to make this record breaking contribution towards research of MS and other neurological conditions.

Read More
article.heroMedia.text

Ocrevus (Ocrelizumab) soon to be available on the PBS

24th August 2017

The TGA approval of Ocrevus (an endorsement it is safe and effective), is the important first step for the drug in this country and on the 18 August 2017, the submission to the Pharmaceutical Benefits Advisory Committee (PBAC) for Pharmaceutical Benefits Scheme (PBS) listing, was successful. Ocrevus is used in relapsing remitting multiple sclerosis (RRMS) and the potential that the associated cost will be removed together with it being more available, is terrific news for the MS community.

Read More
article.heroMedia.text

Show your support

With your support, MSWA are delivering real things to real people living with neurological conditions in Western Australia.

It is easy to show your support. You can buy a raffle ticket, a lottery ticket, even an entertainment book, or simply donate.


Find out more.